2026/2661(DEA)
List of implantable devices and class III devices exempted from the obligation to perform clinical investigations
Basic information
2026/2661(DEA)
DEA - Delegated acts procedure
Supplementing 2012/0266(COD)
Subject
2.10.03 Standardisation, EC/EU standards and trade mark, certification, compliance
3.40.11 Precision engineering, optics, photography, medical
4.20.05 Health legislation and policy
4.60.08 Safety of products and services, product liability
Status
Awaiting committee decision
Key players
-
European Parliament
Committee responsible Rapporteur Appointed SANT
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 20/03/2026 | Non-legislative basic document published | C(2026)01798 | |
| 20/03/2026 | Initial period for examining delegated act 3 month(s) | ||
| 25/03/2026 | Committee referral announced in Parliament |
Technical information
| Procedure reference | 2026/2661(DEA) |
|---|---|
| Procedure type | DEA - Delegated acts procedure |
| Procedure subtype | Examination of delegated act |
| Amendments and repeals | Supplementing 2012/0266(COD) |
| Stage reached in procedure | Awaiting committee decision |
| Committee dossier |
SANT/10/05464
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2026)01798 20/03/2026
Additional information
| Source | Document | Date |
|---|---|---|
| European Commission | EUR-Lex |